Full Text View
Tabular View
No Study Results Posted
Related Studies
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
This study is currently recruiting participants.
Verified April 2013 by National Cancer Institute (NCI)
Study NCT01097304   Information provided by National Cancer Institute (NCI)

First Received on March 31, 2010.   Last Updated on April 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Barrett Esophagus
Esophageal Cancer
Additional conditions recognized in this trial
Esophageal Diseases
Esophageal Neoplasms
More general conditions related to this trial
Digestive System Abnormalities
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Interventions listed in this trial
ursodiol
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Ursodeoxycholic Acid
More general drug interventions related to this trial
Cholagogues and Choleretics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services